| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.021 | 0.9 |